PUBLISHER: GlobalData | PRODUCT CODE: 1410858
PUBLISHER: GlobalData | PRODUCT CODE: 1410858
Peripheral Vascular Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Peripheral Vascular Stents market for the year 2020 and beyond. Peripheral vascular disease (also known as Peripheral artery disease - PAD) is a global public health and socioeconomic problem affecting millions of patients each year. The increasing prevalence of PAD worldwide can be attributed to risk factors and comorbidities such as diabetes, hypertension, obesity, and tobacco use. The aging population, the high prevalence of the disease in the developed countries, and the development of new and improved diagnostic modalities have contributed to increased treatment rates using minimally-invasive techniques, such as angioplasty and stenting. Peripheral stenting involves inserting a stent into the blocked peripheral artery to widen it and allow for normal blood flow through the vessel.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Peripheral Vascular Stents market and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: W. L. Gore & Associates Inc, Becton Dickinson and Co, Cook Group Inc, Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Getinge AB, Cordis Corp, Terumo Corp, Biotronik SE & Co KG, Kyoto Medical Planning Co Ltd, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable